NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced their planned presence at this year’s San Antonio Breast Cancer Symposium (SABCS), including four accepted abstracts for poster presentation ...

GH Research ( ($GHRS) ) just unveiled an update. GH Research PLC announced the presentation of data from its GH001-TRD-201 clinical trial at the ...

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy) data in patients ...

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE: 4502/NYSE:TAK) will present today positive results from its Phase 2b trial of TAK-861 in narcolepsy type 1 (NT1) as late-breaking data ...

Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, announced today that two abstracts have been accepted for poster ...

TG Therapeutics, Inc. has announced its schedule for presenting data on BRIUMVI® (ublituximab-xiiy) at the upcoming American Academy of Neurology 2025 annual meeting in San Diego, California, from ...

Regeneron presents real-world data on EYLEA HD's effectiveness and economic benefits in treating retinal diseases at ARVO 2025. Regeneron Pharmaceuticals announced the upcoming presentation of data on ...

Spend less time wrangling data and more time uncovering opportunities with Bloomberg’s growing number of investment research data products. Purpose-built and curated for rigorous investment research, ...

Do you have a research project to submit but aren’t sure where to begin? The Research and Grant Office (RGO) invites you to Lost in Submission, an event designed to guide you through the process and ...